ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Whitta
|
581 |
199K |
1 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
581
|
199K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Whitta
|
581 |
199K |
5 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
581
|
199K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Whitta
|
581 |
199K |
19 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
581
|
199K
|
19
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR Appoints Business Development Consultant
|
|
Whitta
|
327 |
106K |
9 |
17/02/24 |
17/02/24 |
ASX - By Stock
|
327
|
106K
|
9
|
|
ASX - By Stock
|
PAR |
Re:
Long Term Holders...How Many Shares Are You Hoarding?
|
|
Whitta
|
162 |
86K |
1 |
17/02/24 |
17/02/24 |
ASX - By Stock
|
162
|
86K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR Appoints Business Development Consultant
|
|
Whitta
|
327 |
106K |
5 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
327
|
106K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
PROS ans CONS
|
|
Whitta
|
45 |
13K |
7 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
45
|
13K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR Successful Placement and Fully Underwritten ANREO
|
|
Whitta
|
191 |
56K |
2 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
191
|
56K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Trading Halt
|
|
Whitta
|
71 |
27K |
0 |
19/10/23 |
19/10/23 |
ASX - By Stock
|
71
|
27K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
PARate Day SHare Price 2023
|
|
Whitta
|
122 |
42K |
1 |
05/07/23 |
05/07/23 |
ASX - By Stock
|
122
|
42K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study
|
|
Whitta
|
386 |
163K |
10 |
04/04/23 |
04/04/23 |
ASX - By Stock
|
386
|
163K
|
10
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Trading Halt
|
|
Whitta
|
139 |
63K |
0 |
04/04/23 |
04/04/23 |
ASX - By Stock
|
139
|
63K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Whitta
|
4.1K |
1.9M |
1 |
14/03/23 |
14/03/23 |
ASX - By Stock
|
4.1K
|
1.9M
|
1
|
|
ASX - By Stock
|
PAR |
Re:
The rumours are true - I'm going...
|
|
Whitta
|
108 |
52K |
5 |
13/03/23 |
13/03/23 |
ASX - By Stock
|
108
|
52K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Half Yearly Report and Accounts
|
|
Whitta
|
5 |
2.7K |
7 |
27/02/23 |
27/02/23 |
ASX - By Stock
|
5
|
2.7K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
Mozz Research 2022
|
|
Whitta
|
24 |
9.6K |
3 |
19/12/22 |
19/12/22 |
ASX - By Stock
|
24
|
9.6K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm AGM Presentation
|
|
Whitta
|
141 |
56K |
0 |
29/11/22 |
29/11/22 |
ASX - By Stock
|
141
|
56K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm AGM Presentation
|
|
Whitta
|
141 |
56K |
10 |
29/11/22 |
29/11/22 |
ASX - By Stock
|
141
|
56K
|
10
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm AGM Presentation
|
|
Whitta
|
141 |
56K |
0 |
29/11/22 |
29/11/22 |
ASX - By Stock
|
141
|
56K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm AGM Presentation
|
|
Whitta
|
141 |
56K |
0 |
29/11/22 |
29/11/22 |
ASX - By Stock
|
141
|
56K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm CEO steps down & Appointment of MD
|
|
Whitta
|
213 |
74K |
2 |
23/11/22 |
23/11/22 |
ASX - By Stock
|
213
|
74K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm CEO steps down & Appointment of MD
|
|
Whitta
|
213 |
74K |
5 |
22/11/22 |
22/11/22 |
ASX - By Stock
|
213
|
74K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
Bell Potter Health Care Conference
|
|
Whitta
|
15 |
7.8K |
5 |
08/11/22 |
08/11/22 |
ASX - By Stock
|
15
|
7.8K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
non existent volume
|
|
Whitta
|
6 |
3.3K |
2 |
01/11/22 |
01/11/22 |
ASX - By Stock
|
6
|
3.3K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
OA Biomarkers, 008, and the PPS MoA
|
|
Whitta
|
21 |
11K |
1 |
13/10/22 |
13/10/22 |
ASX - By Stock
|
21
|
11K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Whitta
|
4.1K |
1.9M |
5 |
12/10/22 |
12/10/22 |
ASX - By Stock
|
4.1K
|
1.9M
|
5
|
|
ASX - By Stock
|
PAR |
Re:
ANTI COVID
|
|
Whitta
|
1 |
846 |
3 |
21/09/22 |
21/09/22 |
ASX - By Stock
|
1
|
846
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Whitta
|
4.2K |
3.8M |
3 |
21/09/22 |
21/09/22 |
ASX - By Stock
|
4.2K
|
3.8M
|
3
|
|
ASX - By Stock
|
PAR |
Re:
PARate Day Share Price 2022
|
|
Whitta
|
116 |
51K |
9 |
19/09/22 |
19/09/22 |
ASX - By Stock
|
116
|
51K
|
9
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Successful Completion of Entitlement Offer
|
|
Whitta
|
109 |
39K |
1 |
13/09/22 |
13/09/22 |
ASX - By Stock
|
109
|
39K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Successful Completion of Entitlement Offer
|
|
Whitta
|
109 |
39K |
7 |
13/09/22 |
13/09/22 |
ASX - By Stock
|
109
|
39K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
PAR and the concrete base
|
|
Whitta
|
5 |
2.8K |
6 |
11/09/22 |
11/09/22 |
ASX - By Stock
|
5
|
2.8K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Paramour becomes PAR amour
|
|
Whitta
|
2 |
1.0K |
6 |
30/08/22 |
30/08/22 |
ASX - By Stock
|
2
|
1.0K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Whitta
|
4.2K |
3.8M |
3 |
28/08/22 |
28/08/22 |
ASX - By Stock
|
4.2K
|
3.8M
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Investor Presentation - $66m Capital Raise
|
|
Whitta
|
87 |
35K |
6 |
19/08/22 |
19/08/22 |
ASX - By Stock
|
87
|
35K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Investor Presentation - $66m Capital Raise
|
|
Whitta
|
87 |
35K |
0 |
19/08/22 |
19/08/22 |
ASX - By Stock
|
87
|
35K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Investor Presentation - $66m Capital Raise
|
|
Whitta
|
87 |
35K |
2 |
18/08/22 |
18/08/22 |
ASX - By Stock
|
87
|
35K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm provides MPS Clinical Program update
|
|
Whitta
|
9 |
6.3K |
1 |
08/08/22 |
08/08/22 |
ASX - By Stock
|
9
|
6.3K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm provides MPS Clinical Program update
|
|
Whitta
|
9 |
6.3K |
6 |
08/08/22 |
08/08/22 |
ASX - By Stock
|
9
|
6.3K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Whitta
|
4.2K |
3.8M |
6 |
02/08/22 |
02/08/22 |
ASX - By Stock
|
4.2K
|
3.8M
|
6
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Whitta
|
4.1K |
1.9M |
6 |
16/06/22 |
16/06/22 |
ASX - By Stock
|
4.1K
|
1.9M
|
6
|
|
ASX - By Stock
|
PAR |
Re:
PARate Day Share Price 2022
|
|
Whitta
|
116 |
51K |
3 |
28/04/22 |
28/04/22 |
ASX - By Stock
|
116
|
51K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Fast Track
|
|
Whitta
|
17 |
8.4K |
8 |
13/04/22 |
13/04/22 |
ASX - By Stock
|
17
|
8.4K
|
8
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Whitta
|
4.2K |
3.8M |
0 |
28/02/22 |
28/02/22 |
ASX - By Stock
|
4.2K
|
3.8M
|
0
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Whitta
|
4.1K |
1.9M |
2 |
16/02/22 |
16/02/22 |
ASX - By Stock
|
4.1K
|
1.9M
|
2
|
|
ASX - By Stock
|
PAR |
Re:
PAR General discussion
|
|
Whitta
|
339 |
138K |
3 |
10/02/22 |
10/02/22 |
ASX - By Stock
|
339
|
138K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Media in the US
|
|
Whitta
|
29 |
11K |
2 |
26/01/22 |
26/01/22 |
ASX - By Stock
|
29
|
11K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Whitta
|
4.1K |
1.9M |
14 |
23/11/21 |
23/11/21 |
ASX - By Stock
|
4.1K
|
1.9M
|
14
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm CEO Paul Rennie to transition to Non-Exec Chairman
|
|
Whitta
|
49 |
19K |
6 |
22/11/21 |
22/11/21 |
ASX - By Stock
|
49
|
19K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PARADIGM CLEARED FOR PHASE 3 TRIAL BY US FDA
|
|
Whitta
|
191 |
75K |
11 |
03/11/21 |
03/11/21 |
ASX - By Stock
|
191
|
75K
|
11
|
|